Funding awarded
- CAROTID-MAP Carotid Atherosclerotic Risk Assessment Through Imaging and Prediction awarded by National Institute on Minority Health & Health Disparities Co-Investigator 2025 - 2030
- Anticoagulation in Intracerebral Hemorrhage Survivors with Atrial Fibrillation and Imaging features of Cerebral Amyloid Angiopathy and Small Vessel Disease awarded by American Heart Association Co-Investigator 2025 - 2030
- Brain Estrogen Imaging and Neuroendocrine Risk Identification: The Gateway to Alzheimer''s Prevention in Women awarded by Wellcome Leap, Inc. Co-Investigator 2025 - 2028
- Quantitative cerebral oxygen metabolic imaging of acute ischemic stroke awarded by National Institute of Neurological Disorders & Stroke Co-Principal Investigator 2024 - 2029
- Quantitative susceptibility mapping for stroke risk prediction of vulnerable carotid plaques awarded by National Institute of Neurological Disorders & Stroke Co-Principal Investigator 2022 - 2027
- StrokeNet -NCC awarded by National Institute of Neurological Disorders & Stroke Principal Investigator Subaward 2023 - 2028
- ASPIRE-per pt-Cincinnati - Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) awarded by National Institute of Neurological Disorders & Stroke Principal Investigator Subaward 2019 - 2026
- ASPIRE-administrative-Yale, Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) awarded by American Heart Association Principal Investigator Subaward 2019 - 2026